The Comprehensive Sickle Cell and Thalassemia Program at Nationwide Children's Hospital is home to over 280 children, adolescents and young adults, with sickle cell anemia and other disorders of hemoglobin including beta thalassemia, emphasizing primary, secondary and tertiary prevention and treatment using a multidisciplinary team approach.
Nationwide Children’s program is recognized as one of six selected clinical centers for the management of children with sickle cell anemia by the Ohio Department of health, and oversees newborn screening, counseling, clinical management of acute complications and long-term follow –up care for the largest region of the state.
To see current Sickle Cell Anemia clinical studies being conducted at Nationwide Children's Hospital, search the options below.
What is the purpose of this study?
We want to look at the effects of different birth control methods on bone health in young women with sickle cell.
Who can participate in this study?
We are looking for young women between the ages of 12-29 years who have sickle cell disease.
We are looking for women who are on birth control AND women who are not. These women should be between 12-29 years of age and have sickle cell disease.
What will happen during the study?
There are two (2) study visits at Nationwide Children's Hospital.
They will be six (6) months apart and will last about two (2) hours each.
Each visit will require a blood draw, answering a few questions, and having a DEXA scan.
All testing is at no cost to participants.
Participants will be compensated for their time.
What is a DEXA scan?
A DEXA scan is a quick, non-painful test that allows us to look at the health of your bones.
How do I get more information about the study?
If you are interested in participating in this study or for more information, please contact Kristina Harrell by email at Kristina.Harrell@NationwideChildrens.org or by phone at 614-722-3250.